These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 30343508)

  • 61. The acute effects of 30 mg vs 60 mg of intravenous Fasudil on patients with congenital heart defects and severe pulmonary arterial hypertension.
    Ruan H; Zhang Y; Liu R; Yang X
    Congenit Heart Dis; 2019 Jul; 14(4):645-650. PubMed ID: 31166081
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Oral therapies for pulmonary arterial hypertension: endothelin receptor antagonists and phosphodiesterase-5 inhibitors.
    Channick R; Preston I; Klinger JR
    Clin Chest Med; 2013 Dec; 34(4):811-24. PubMed ID: 24267306
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.
    Hussain I; Mohammed SF; Forfia PR; Lewis GD; Borlaug BA; Gallup DS; Redfield MM
    Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Circulating endothelial cells in refractory pulmonary hypertension in children: markers of treatment efficacy and clinical worsening.
    Levy M; Bonnet D; Mauge L; Celermajer DS; Gaussem P; Smadja DM
    PLoS One; 2013; 8(6):e65114. PubMed ID: 23762293
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide.
    Lepore JJ; Maroo A; Bigatello LM; Dec GW; Zapol WM; Bloch KD; Semigran MJ
    Chest; 2005 May; 127(5):1647-53. PubMed ID: 15888841
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Role of sildenafil in acute posttransplant right ventricular dysfunction: successful experience in 13 consecutive patients.
    De Santo LS; Mastroianni C; Romano G; Amarelli C; Marra C; Maiello C; Galdieri N; Della Corte A; Cotrufo M; Caianiello G
    Transplant Proc; 2008; 40(6):2015-8. PubMed ID: 18675118
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sildenafil improves exercise hemodynamics in Fontan patients.
    Van De Bruaene A; La Gerche A; Claessen G; De Meester P; Devroe S; Gillijns H; Bogaert J; Claus P; Heidbuchel H; Gewillig M; Budts W
    Circ Cardiovasc Imaging; 2014 Mar; 7(2):265-73. PubMed ID: 24478333
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tadalafil: a long-acting phosphodiesterase-5 inhibitor for the treatment of pulmonary arterial hypertension.
    Arif SA; Poon H
    Clin Ther; 2011 Aug; 33(8):993-1004. PubMed ID: 21762988
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Choice of Initial Oral Therapy for Pulmonary Arterial Hypertension: Age and Long-Term Survival.
    Heresi GA; Love TE; Tonelli AR; Highland KB; Dweik RA
    Am J Respir Crit Care Med; 2018 Oct; 198(8):1090-1093. PubMed ID: 29949380
    [No Abstract]   [Full Text] [Related]  

  • 70. Prognostic Value of Pulmonary Artery Compliance in Patients with Pulmonary Arterial Hypertension Associated with Adult Congenital Heart Disease.
    Cheng XL; Liu ZH; Gu Q; Ni XH; Luo Q; Zhao ZH; He JG; Xiong CM
    Int Heart J; 2017 Oct; 58(5):731-738. PubMed ID: 28966315
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical efficacy and safety of switch from bosentan to macitentan in children and young adults with pulmonary arterial hypertension.
    Aypar E; Alehan D; Karagöz T; Aykan HH; Ertugrul İ
    Cardiol Young; 2018 Apr; 28(4):542-547. PubMed ID: 29233198
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effect of intravenous iloprost on pulmonary artery hypertension after paediatric congenital heart surgery.
    Onan IS; Ozturk E; Yildiz O; Altin HF; Odemis E; Erek E
    Interact Cardiovasc Thorac Surg; 2016 Feb; 22(2):194-9. PubMed ID: 26604214
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Sildenafil for pulmonary hypertension secondary to congenital heart diseases.
    Gupta A; Kerkar P
    Indian Heart J; 2007; 59(4):342-5. PubMed ID: 19126940
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of the phosphodiesterase type 5 inhibitor tadalafil on pulmonary hemodynamics in a canine model of pulmonary hypertension.
    Hori Y; Kondo C; Matsui M; Yamagishi M; Okano S; Chikazawa S; Kanai K; Hoshi F; Itoh N
    Vet J; 2014 Nov; 202(2):334-9. PubMed ID: 25178687
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Response to a single dose of sildenafil in single-ventricle patients: an echocardiographic evaluation.
    Jackson KW; Butts RJ; Svenson AJ; McQuinn TC; Atz AM
    Pediatr Cardiol; 2013 Oct; 34(7):1739-42. PubMed ID: 22806713
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease.
    Benza RL; Rayburn BK; Tallaj JA; Coffey CS; Pinderski LJ; Pamoukian SV; Bourge RC
    Chest; 2006 Apr; 129(4):1009-15. PubMed ID: 16608951
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Outcomes of pulmonary arterial hypertension therapy in Australia: is monotherapy adequate?
    Moonen A; Garsia R; Youssef P; Torzillo P; Corte T; Boehm C; Cordina R; Celermajer D; Lau E
    Intern Med J; 2017 Oct; 47(10):1124-1128. PubMed ID: 28560817
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Relation of Cytokine Profile to Clinical and Hemodynamic Features in Young Patients With Congenital Heart Disease and Pulmonary Hypertension.
    Zorzanelli L; Maeda N; Clavé M; Thomaz A; Galas F; Rabinovitch M; Lopes A
    Am J Cardiol; 2017 Jan; 119(1):119-125. PubMed ID: 28247848
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sildenafil for Pulmonary Hypertension in the Early Postoperative Period After Mitral Valve Surgery.
    Ram E; Sternik L; Klempfner R; Eldar M; Goldenberg I; Peled Y; Raanani E; Kogan A
    J Cardiothorac Vasc Anesth; 2019 Jun; 33(6):1648-1656. PubMed ID: 30685151
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
    Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
    Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.